Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Outcome of antegrade radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level >100 ng/ml.

Urakami S, Yonese J, Yamamoto S, Yuasa T, Kitsukawa S, Numao N, Kubo Y, Ito M, Sukegawa G, Yasuda Y, Ishikawa Y, Fukui I.

Urol Int. 2011;87(2):175-81. doi: 10.1159/000328048. Epub 2011 Aug 18.

PMID:
21849759
2.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
4.

Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.

Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.

BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.

5.
6.

Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.

Vargas C, Kestin LL, Weed DW, Krauss D, Vicini FA, Martinez AA.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):714-24.

PMID:
15708249
7.

Risk stratification of high-grade prostate cancer treated with antegrade radical prostatectomy with intended wide resection.

Yamamoto S, Kawakami S, Yonese J, Fujii Y, Tsukamoto T, Ohkubo Y, Komai Y, Ishikawa Y, Fukui I.

Jpn J Clin Oncol. 2009 Jun;39(6):387-93. doi: 10.1093/jjco/hyp032. Epub 2009 Apr 24.

8.
10.
11.

Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors.

Joniau S, Hsu CY, Gontero P, Spahn M, Van Poppel H.

Scand J Urol Nephrol. 2012 Jun;46(3):164-71. doi: 10.3109/00365599.2011.637956. Epub 2012 Feb 27.

PMID:
22364377
12.

Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.

Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK.

Urology. 2004 Jul;64(1):84-9.

PMID:
15245941
13.

Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables.

Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H.

J Urol. 2002 Jan;167(1):117-22. Erratum in: J Urol. 2004 Feb;171(2 Pt 1):811.

PMID:
11743287
14.

Neoadjuvant hormone therapy before salvage radiotherapy for an increasing post-radical prostatectomy serum prostate specific antigen level.

Tiguert R, Rigaud J, Lacombe L, Laverdière J, Fradet Y.

J Urol. 2003 Aug;170(2 Pt 1):447-50.

PMID:
12853796
15.

Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8.

Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS.

BJU Int. 2003 Oct;92(6):539-44.

16.

The outcome of patients with pathological Gleason score >or=8 prostate cancer after radical prostatectomy.

Rodriguez-Covarrubias F, Larre S, De La Taille A, Abbou CC, Salomon L.

BJU Int. 2008 Feb;101(3):305-7. Epub 2007 Oct 17.

17.
18.

Radical prostatectomy for high-risk prostate cancer: biochemical outcome.

Kawamorita N, Saito S, Ishidoya S, Ito A, Saito H, Kato M, Arai Y.

Int J Urol. 2009 Sep;16(9):733-8. doi: 10.1111/j.1442-2042.2009.02352.x. Epub 2009 Aug 5.

19.

Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.

Blute ML, Bostwick DG, Bergstralh EJ, Slezak JM, Martin SK, Amling CL, Zincke H.

Urology. 1997 Nov;50(5):733-9.

PMID:
9372884
20.

Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.

Amling CL, Lerner SE, Martin SK, Slezak JM, Blute ML, Zincke H.

J Urol. 1999 Mar;161(3):857-62; discussion 862-3.

PMID:
10022701
Items per page

Supplemental Content

Write to the Help Desk